Barriers and facilitators of ongoing engagement in substance use treatment programmes among people with HIV in South Africa: A qualitative analysis [0.03%]
南非艾滋病毒携带者持续参与物质使用治疗计划的障碍和促进因素：定性分析
Thanusha Pillay,Stefani Du Toit,Chiara Sforza et al.
Thanusha Pillay et al.
Background: South Africa has a high prevalence of HIV and substance use, with 13% of the population meeting criteria for lifetime substance use disorder (SUD). Substance disorders are associated with adverse health outcom...
Determinants of drop-offs in the targeted universal tuberculosis testing care cascade among people with HIV in rural and urban facilities in South Africa [0.03%]
南非城乡艾滋病毒患者中目标普及结核病检测试点关怀全流程脱落的影响因素分析
Katlego Motlhaoleng,Kgomotso Vilakazi-Nhlapo,Kate Shearer et al.
Katlego Motlhaoleng et al.
Background: Targeted Universal Tuberculosis Testing (TUTT) is a strategy for early tuberculosis (TB) detection among people with HIV (PWH); however, drop-offs at key cascade stages limit its effectiveness. ...
Identifying sexual behavioural choices when commencing pre-exposure prophylaxis: Findings from a public health facility in eThekwini, KwaZulu-Natal, South Africa [0.03%]
南非夸祖鲁-纳塔尔省埃 thékwini 公共卫生机构开始暴露前预防时的身份行为选择：发现种族差异
Jyotika Basdav,Poovendhree Reddy,Firoza Haffejee
Jyotika Basdav
Background: HIV/AIDS continues to be of concern, particularly in South Africa, where the current prevalence is 12.7%. Objectives: This ...
Healthcare services provided to pregnant women with HIV and their outcomes at primary healthcare clinics in the Free State province, South Africa [0.03%]
南非弗朗斯胡特省初级保健诊所为感染HIV的孕妇提供的医疗服务及其结果
Olive P Khaliq,Ahmad Jassen,Nomakhuwa E Tabane et al.
Olive P Khaliq et al.
Background: HIV prevalence among pregnant women in South Africa was very high at 25.3% of infections reported in 2022. KwaZulu-Natal province had the highest HIV prevalence of 34.2%, followed by the Eastern Cape with 32.0...
Perceptions of adolescents and young adults failing antiretroviral therapy on adherence in Gauteng, South Africa [0.03%]
南非豪登省青少年和年轻成年人艾滋病抗病毒治疗失败对依从性的认知研究
Regina M Molete,Memme G Makua,Bandile E Ndlazi
Regina M Molete
Background: The management of HIV among adolescents and young adults (AYAs) living with HIV is often complicated by systemic barriers within healthcare services, particularly communication challenges, inadequate support s...
Retrospective analysis of CD4 trends at district levels in South Africa between 2013 and 2023 [0.03%]
南非2013年至2023年各地区CD4趋势的回顾性分析
Naseem Cassim,Pedro da Silva,Deborah K Glencross et al.
Naseem Cassim et al.
Background: South Africa has the largest HIV epidemic globally. Despite the scale-up of antiretroviral therapy, people living with HIV still present with CD4 ≤ 200 cells/µL because of possible treatment interruptions an...
A cross-sectional study of viral load suppression among youth living with HIV in Namibia [0.03%]
Namibia青少年HIV感染者病毒载量抑制的横断面研究
Jacques W N Kamangu,Sheillah H Mboweni
Jacques W N Kamangu
Background: Meeting the Joint United Nations Programme on HIV/AIDS targets and ending AIDS by 2030 requires global efforts, with a particular focus on older adolescents living with HIV (OALHIV) and younger adults living w...
Retention in care of people on antiretroviral therapy who inject drugs in South Africa [0.03%]
南非接受抗逆转录病毒治疗的吸毒者留存率
Phumzile C Mngomezulu,Rifqah A Roomaney,Brian E van Wyk
Phumzile C Mngomezulu
Background: Retention of people who inject drugs (PWID) on antiretroviral therapy (ART) is critical for viral suppression. However, PWID, a key population, traditionally have poor retention in care (RiC). ...
Barriers and facilitators to HIV index contact testing in facility and community settings [0.03%]
医疗机构与社区HIV高危接触追踪的阻力和促进因素
Nyeleti Pretty Chauke,Cathrine Chinyandura,Fezile Buthelezi et al.
Nyeleti Pretty Chauke et al.
Background: The WHO emphasises contact investigation of people with HIV for case finding. However, satisfactory implementation of index contact testing remains challenging in Johannesburg. ...
Rapid development of drug resistance during initial dolutegravir-based antiretroviral therapy of an infant with HIV [0.03%]
初始基于多替拉韦的抗逆转录病毒治疗婴儿HIV期间药物耐药性迅速发展
Natasha L O&#x;Connell,Tara-Lee von Mollendorff,Gert van Zyl et al.
Natasha L O&#x;Connell et al.
Dolutegravir resistance is predominantly reported in antiretroviral therapy-experienced individuals. We describe an infant who developed high-level resistance to abacavir, lamivudine, and dolutegravir within 97 days of initiation, despite i...